Mexico vs East Timor: Access to anti-retroviral drugs, female (%)
Mexico
58.0%
in 2024
East Timor
57.0%
in 2024
Mexico rank
105th
East Timor rank
108th
Access to anti-retroviral drugs, female (%) over time
- Mexico
- East Timor
How they compare
Mexico currently reports 58.0% against 57.0% in East Timor, a difference of 1.0%.
Across all 23 years both countries report, Mexico has been ahead every year.
Mexico ranks 105th and East Timor ranks 108th of 141 countries.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mexico | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.0% | 1.6% | 16.4% | Mexico |
| 2010s | 44.6% | 22.1% | 22.5% | Mexico |
| 2020s | 58.6% | 49.0% | 9.6% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mexico or East Timor?
- Mexico, at 58.0% against 57.0% in East Timor as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mexico and East Timor?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Mexico and East Timor?
- 23 years are reported by both, from 2000 to 2024.
- How do Mexico and East Timor rank globally for access to anti-retroviral drugs, female?
- Mexico ranks 105th and East Timor ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.